MHCC-97H Cells
USD$375.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The MHCC-97H cell line is a human hepatocellular carcinoma (HCC) model with a high metastatic potential. It was established from the MHCC97 parental line, derived from a male patient with HCC linked to hepatitis B virus (HBV) infection. MHCC-97H has been extensively utilized in studies focusing on cancer metastasis, particularly because it consistently demonstrates spontaneous lung metastases following orthotopic implantation in mouse models. This feature makes it a valuable resource for exploring the mechanisms of HCC progression and metastasis. MHCC-97H cells exhibit an epithelial morphology and possess key genetic and molecular characteristics contributing to their aggressive metastatic behavior. The line is noted for its upregulation of matrix metalloproteinases (MMP-2 and MMP-9), which facilitate extracellular matrix degradation and promote invasive capabilities. Proteomic analyses have identified several differentially expressed proteins in MHCC-97H compared to its low-metastatic counterpart MHCC-97L, including elevated levels of pyruvate kinase M2 and S100 calcium-binding protein A4. These findings highlight their utility in studying the molecular pathways governing metastasis. MHCC-97H is used in preclinical research for testing therapeutic strategies targeting metastasis. In vivo models involving this cell line allow researchers to investigate the efficacy of treatments aimed at mitigating metastatic spread, especially to the lungs. Additionally, MHCC-97H aids in the development of biomarkers for predicting HCC aggressiveness and in studying the tumor microenvironment's role in metastasis. These applications underscore its critical importance in advancing our understanding of hepatocellular carcinoma biology. |
|---|---|
| Organism | Human |
| Tissue | Liver |
| Disease | Adult hepatocellular carcinoma |
| Synonyms | MHCC 97-H, MHCC97-H, MHCC97H |
Characteristics
| Age | 39 years |
|---|---|
| Gender | Male |
| Ethnicity | Chinese |
| Growth properties | Adherent |
Regulatory Data
| Citation | MHCC-97H (Cytion catalog number 305442) |
|---|---|
| Biosafety level | 2 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_4972 |
Biomolecular Data
| Tumorigenic | High metastatic potential |
|---|---|
| Viruses | Transformant: Hepatitis B virus (HBV) |
| Mutational profile | Mutation: BRD7, p.Glu277Glyfs*18 (c.830_831delAG); Mutation: KEAP1, p.Pro445Glnfs*13 (c.1334delC); Mutation: TP53, p.Glu51Ter (c.151G>T) |
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1.5 to 4 x 104 cells/cm2 |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305442-091225 | Certificate of Analysis | 02. Mar. 2026 | 305442 |